Back to Journals » OncoTargets and Therapy » Volume 10
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
14,637 | Dovepress* | 11,546+ | 1,171 | 12,717 | |
PubMed Central* | 3,091 | 537 | 3,628 | ||
Totals | 14,637 | 1,708 | 16,345 | ||
*Since 5 October 2017 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 1 |
View citations on PubMed Central and Google Scholar